Companies: 10,638     total market cap: NZ$235.202 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novavax
NVAX
#5751
Rank
NZ$1.94 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$12.00
Share price
0.73%
Change (1 day)
-14.98%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of September 2025 : -NZ$0.28 Billion

According to Novavax's latest financial reports the company has -NZ$0.28 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-NZ$1.11 Billion-2.43%
2023-12-31$-NZ$1.14 Billion13.51%
2022-12-31$-NZ$1 Billion93.97%
2021-12-31$-NZ$0.52 Billion-159.23%
2020-12-31$NZ$0.86 B-414.72%
2019-12-31$-NZ$0.28 Billion10.32%
2018-12-31$-NZ$0.26 Billion74.78%
2017-12-31$-NZ$0.15 Billion1689.1%
2016-12-31$-NZ$8.01 Million-101.87%
2015-12-31$NZ$0.42 B45.91%
2014-12-31$NZ$0.29 B18.5%
2013-12-31$NZ$0.24 B153.55%
2012-12-31$NZ$97.53 M41.37%
2011-12-31$NZ$68.99 M-9.86%
2010-12-31$NZ$76.54 M-20.53%
2009-12-31$NZ$96.3 M22.87%
2008-12-31$NZ$78.38 M-4.79%
2007-12-31$NZ$82.33 M-38.3%
2006-12-31$NZ$0.13 B83.68%
2005-12-31$NZ$72.64 M55.75%
2004-12-31$NZ$46.64 M-15.65%
2003-12-31$NZ$55.29 M258.46%
2002-12-31$NZ$15.42 M-76.7%
2001-12-31$NZ$66.2 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-NZ$0.49 Billion 79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.29 B-942.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.01 B-471.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.68 Billion 147.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$79.81 B-29,442.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$161.63 B-59,520.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$77.69 B-28,664.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
NZ$13.05 M-104.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$36.76 B-13,616.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$1.03 B-481.92%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com